- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2013
- Public Summary Document (PSD) November 2013 PBAC Meeting - PDF
Plerixafor – November 2013
Plerixafor 24 mg/1.2 mL, injection, subcutaneous infusion, 1.2 mL vial Mozobil®
Last updated
8 November 2023